Skip to main content
Premium Trial:

Request an Annual Quote

Venter to Consolidate Three Non-Profits into Single Institute

NEW YORK, Sept. 29 (GenomeWeb News) - Craig Venter today announced that he would merge three non-profit research organizations that he currently directs into a single umbrella organization called the J. Craig Venter Institute.


The three organizations that will be merged include the Center for the Advancement of Genomics, the Institute for Biological Energy Alternatives, and the J. Craig Venter Science Foundation Joint Technology Center. They were founded nearly three years ago and conduct basic science genomic research, high-throughput genomic sequencing, and genomic policy research.


"We did this so we could save some money and to make it easier to manage," Venter told GenomeWeb News yesterday at TIGR's annual GSAC meeting in Washington.


TIGR, which is an affiliated organization, will continue to receive support from the J. Craig Venter Science Foundation.


Among the research programs underway at the Venter Institute are a study of the genetic causes and potential genomic solutions to diseases such as cancer, which is led by Robert Strausberg. Hamilton Smith is leading a couple of research projects, including research on new methodologies to synthesize large segments of DNA to eventually enable the construction of whole artificial chromosomes, as well as the biological production of cleaner and more efficient fuel production, primarily hydrogen.


According to a statement issued by Venter, the three organizations have nearly 200 employees and a budget of more than $50 million.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.